Newly published results from a Phase 2 clinical trial into the efficacy of MDMA-assisted psychotherapy in treating PTSD have revealed striking success, with 76 percent of subjects not meeting the standard clinical criteria for PTSD 12 months after receiving the treatment.
Continue Reading
A massive study spanning 30 years of data and examining a cohort of over one million people has found a strong association between persons suffering from stress disorders, including PTSD, and an increased risk of developing autoimmune diseases such as arthritis and Crohn’s disease.
Continue Reading
Scientists have directly identified the cluster of neurons in the brain responsible for recalling long-term memories of traumatic experiences, helping answer the question of whether therapy suppresses fear-based memories or if it actually rewrites those memories.
Continue Reading
Intriguing new research suggests that a particular bacteria may have beneficial anti-inflammatory effects on the brain. Early studies in rodent models found that through injections of the bacteria the animals can be "immunized" against displaying anxious responses to stressful situations.
Continue Reading
Biologists at UCLA have effectively transferred a memory from a trained snail into the mind of an untrained one. The experiment could eventually lead to new treatments for restoring memory in Alzheimer’s patients or to reduce traumatic memories.
Continue Reading
The results of a clinical trial in MDMA-assisted psychotherapy for the treatment of PTSD have just been published in the journal The Lancet Psychiatry. These impressive results led to the FDA expediting the new treatment and last year granting it Breakthrough Therapy Designation.
Continue Reading
An anonymous cryptocurrency millionaire recently launched a fund to donate $86 million in Bitcoin to charity. One of the biggest donations so far is to MAPS, an organization working to turn MDMA into a legal PTSD treatment.
Continue Reading
This is the story of how a group of determined researchers spent 35 years battling a system hell-bent on keeping a drug with proven medical benefits out of the hands of the public. Rick Doblin’s long, strange MDMA trip.
Continue Reading
Currently, PTSD is usually treated with psychotherapy and antidepressants, but those aren’t always effective. Now a study conducted at Wake Forest Baptist Medical Center has found that a novel form of treatment reduced symptoms of the disorder by letting patients “hear” their own brainwaves.
Continue Reading
Recurrent unwanted thoughts are a key feature of conditions such as anxiety, post-traumatic stress disorder (PTSD), depression and schizophrenia. Now, in a step towards better-treating these disorders, scientists have identified a chemical in the brain that lets most people suppress such thoughts.
Continue Reading
See the stories that matter in your inbox every morning